KRSA Korsana Biosciences, Inc.
30.07USD-6.29%Mkt Cap: 1.37B $P/E: —1d ago
Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designe…
Industry Peers
Biotechnology$131.98BUSDP/E 30.3
$84.02BUSDP/E 20.2
$83.03BUSD
$66.33BUSD
$57.32BUSDP/E 23.7
$55.50BUSDP/E 30.6
$55.08BUSDP/E 31.5
$41.65BUSDP/E 65.5
$39.91BUSD
$37.72BUSDP/E 34.7
$30.35BUSDP/E 38.2
$27.58BUSDP/E 37.0
$27.47BUSDP/E 35.2
$26.39BUSD
$23.63BUSDP/E 14.9
$21.87BUSD
$20.74BUSD
$16.19BUSDP/E 20.6
$16.18BUSDP/E 18.8
$14.58BUSDP/E 37.6